Intellia Therapeutics
ISIN US45826J1051
|WKN A2AG6H
Overview
Description
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Chart
Financials
Key metrics
| Market capitalisation, EUR | 1,185.40 m |
| EPS, EUR | -5.02 |
| P/B ratio | 1.28 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 33.55 m |
| Net income, EUR | -445.09 m |
| Profit margin | -1,326.51% |
What ETF is Intellia Therapeutics in?
There are 33 ETFs which contain Intellia Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Intellia Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.03% | Equity United States Small Cap | 1,375 | 0.14% | 51 | +23.73% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,953 | 0.28% | 7 | +16.81% | A2DWAC | IE00BDGV0746 |
| Amundi MSCI Disruptive Technology ESG Screened UCITS ETF Acc | 0.05% | Equity World Technology Social/Environmental Innovation | 234 | 0.45% | 145 | +22.91% | LYX0ZG | LU2023678282 |
| Amundi MSCI Robotics & AI ESG Screened UCITS ETF Acc | 0.05% | Equity World Technology Social/Environmental Artificial Intelligence | 162 | 0.40% | 915 | +24.40% | A2JSC9 | LU1861132840 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.05% | Equity United States Small Cap | 1,030 | 0.30% | 211 | +19.82% | A0Q8H2 | IE00B3CNHJ55 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 0.48% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | -5.98% | A3CY21 | IE000O8KMPM1 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.03% | Equity United States Small Cap | 1,375 | 0.14% | 164 | +24.21% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.00% | Equity United States Multi-Factor Strategy | 1,953 | 0.25% | 32 | +27.51% | A2DND0 | IE00BDGV0308 |
| UBS ETF (IE) MSCI USA Small Cap ESG Leaders UCITS ETF (USA) A-acc | 0.05% | Equity United States Small Cap | 720 | 0.20% | 580 | - | A40EWV | IE000XFXBGR0 |
| iShares MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,321 | 0.35% | 4,796 | +16.96% | A2DWBY | IE00BF4RFH31 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity North America Social/Environmental | 1,453 | 0.12% | 193 | +34.19% | A3DJRE | IE000O58J820 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.05% | Equity United States Small Cap | 1,797 | 0.30% | 4,711 | +20.67% | A1XFN1 | IE00BJ38QD84 |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.45% | Equity World Health Care Social/Environmental Innovation | 53 | 0.35% | 5 | +6.51% | A3DSGJ | IE000B9PQW54 |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0.29% | Equity World Health Care Social/Environmental Innovation | 97 | 0.30% | 3 | +7.25% | DBX0R2 | IE000KD0BZ68 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Acc) | 0.00% | Equity World | 3,576 | 0.17% | 2,175 | +25.00% | A1JJTD | IE00B3YLTY66 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,953 | 0.25% | 81 | +27.55% | A2JSD1 | IE00BDGV0415 |
| ARK Innovation UCITS ETF USD Accumulating | 2.33% | Equity World Innovation | 32 | 0.75% | 28 | - | A408AW | IE000GA3D489 |
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,545 | 0.45% | 890 | +16.42% | A1W56P | IE00BCBJG560 |
| ARK Genomic Revolution UCITS ETF USD Accumulating | 3.77% | Equity World Health Care Innovation | 37 | 0.75% | 4 | - | A408AY | IE000O5M6XO1 |
| Global X Genomics & Biotechnology UCITS ETF | 2.82% | Equity World Health Care Biotech | 42 | 0.50% | 9 | -6.41% | A2QRCP | IE00BM8R0N95 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,774 | 0.24% | 407 | +26.93% | A2QL8V | IE00BNG8L385 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.05% | Equity United States Small Cap | 1,490 | 0.30% | 2,016 | +20.53% | A1XEJT | IE00BJZ2DD79 |
| Fidelity Sustainable Research Enhanced US Equity UCITS ETF Acc | 0.01% | Equity United States Social/Environmental | 201 | 0.20% | 513 | +35.65% | A2P0ZN | IE00BKSBGS44 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Dist) | 0.00% | Equity World | 3,576 | 0.17% | 14 | - | A40F93 | IE000DD75KQ5 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,953 | 0.28% | 24 | +15.18% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.04% | Equity United States Small Cap | 1,602 | 0.43% | 2,211 | +20.31% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.15% | Equity United States Health Care Biotech | 213 | 0.35% | 30 | +11.66% | A2JDYM | IE00BDZVHG35 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.15% | Equity United States Health Care Biotech | 213 | 0.35% | 436 | +11.01% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.01% | Equity United States Small Cap | 1,695 | 0.30% | 564 | +18.04% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.02% | Equity World Small Cap | 2,278 | 0.35% | 59 | +16.12% | A3C14G | IE000T9EOCL3 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.00% | Equity North America Social/Environmental | 1,453 | 0.12% | 29 | +34.18% | A3DJRF | IE000L2ZNB07 |
| HSBC MSCI World Small Cap ESG UCITS ETF USD (Acc) | 0.03% | Equity World Small Cap | 1,144 | 0.25% | 59 | +14.91% | A3DUNV | IE000C692SN6 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,774 | 0.24% | 450 | +26.57% | A2QL8U | IE00BNG8L278 |
Performance
Returns overview
| YTD | -61.41% |
| 1 month | -6.36% |
| 3 months | -41.89% |
| 6 months | -49.11% |
| 1 year | -58.61% |
| 3 years | -89.52% |
| 5 years | -17.99% |
| Since inception (MAX) | -52.54% |
| 2023 | -13.03% |
| 2022 | -67.45% |
| 2021 | +117.74% |
| 2020 | +245.64% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 59.46% |
| Volatility 3 years | 66.54% |
| Volatility 5 years | 75.81% |
| Return per risk 1 year | -0.98 |
| Return per risk 3 years | -0.79 |
| Return per risk 5 years | -0.05 |
| Maximum drawdown 1 year | -63.08% |
| Maximum drawdown 3 years | -89.86% |
| Maximum drawdown 5 years | -92.59% |
| Maximum drawdown since inception | -92.59% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.